Federal Institute for Risk Assessment, Max-Dohrn-Straße 8-10, 10589, Berlin, Germany.
Department of Chemistry and Biochemistry, Florida International University, Miami, FL, USA.
Arch Toxicol. 2016 Aug;90(8):2025-36. doi: 10.1007/s00204-015-1591-9. Epub 2015 Sep 15.
The ingestion of seafood contaminated with the marine biotoxin okadaic acid (OA) can lead to diarrhetic shellfish poisoning with symptoms like nausea, vomiting and abdominal cramps. Both rat and the human hepatic cytochrome P450 monooxygenases (CYP) metabolize OA. However, liver cell toxicity of metabolized OA is mainly unclear. The aim of our study was to detect the cellular effects in HepG2 cells exposed to OA in the presence of recombinant CYP enzymes of both rat and human for the investigation of species differences. The results should be set in correlation with a CYP-specific metabolite pattern. Comparative metabolite profiles of OA after incubation in rat and human recombinant CYP enzymes were established by using LC-MS/MS technique. Results demonstrated that metabolism of OA to oxygenated metabolites correlates with detoxification which was mainly catalyzed by human CYP3A4 and CYP3A5. Detoxification by rat Cyp3a1 was lower compared to human CYP3A enzymes and activation of OA by Cyp3a2 was observed, coincident with minor overall conversion capacity of OA. By contrast human and rat CYP1A2 seem to activate OA into cytotoxic intermediates. In conclusion, different mechanisms of OA metabolism may occur in the liver. At low OA doses, the human liver is likely well protected against cytotoxic OA, but for high shellfish consumers a potential risk cannot be excluded.
食用受海洋生物毒素 okadaic 酸(OA)污染的海鲜可能导致腹泻性贝类中毒,出现恶心、呕吐和腹部痉挛等症状。大鼠和人类的肝细胞细胞色素 P450 单加氧酶(CYP)都能代谢 OA。然而,代谢后的 OA 对肝细胞的毒性主要还不清楚。我们的研究目的是检测在存在大鼠和人重组 CYP 酶的情况下,OA 暴露对 HepG2 细胞的细胞效应,以研究物种差异。结果应与 CYP 特异性代谢物模式相关联。通过 LC-MS/MS 技术建立了 OA 在大鼠和人重组 CYP 酶孵育后的比较代谢物图谱。结果表明,OA 向含氧代谢物的代谢与解毒相关,主要由人 CYP3A4 和 CYP3A5 催化。大鼠 Cyp3a1 的解毒作用低于人 CYP3A 酶,并且观察到 Cyp3a2 对 OA 的激活,同时 OA 的整体转化能力较小。相比之下,人 CYP1A2 和大鼠 CYP1A2 似乎能将 OA 激活成细胞毒性中间体。总之,OA 的代谢可能在肝脏中发生不同的机制。在低剂量 OA 的情况下,人类肝脏可能很好地免受细胞毒性 OA 的侵害,但对于高贝类消费者,不能排除潜在的风险。